SEMINAR: DEVELOPABILITY ASSESSMENT OF THERAPEUTIC ANTIBODIES - A CONCEPT FOR EARLY LEAD SELECTION | THORSTEN LORENZ, PHD - NOVARTIS PHARMA AG 31 May 16 Host: Manuel Carrondo
